This inventor holds 17 USPTO granted patents and 4 published patent applications and 7 EPO patents, primarily in Bioconjugate Chemistry. Top assignees: Fresenius Kabi Deutschland Gmbh, Beiersdorf Ag, Gesellschaft Fur Biotechnologische Forschung Mbh. Active years: 1997-2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Festeburg, DE (1997)
- Hamburg, DE (2000)
- Butzbach, DE (1999 - 2014)
Company Filing History:
10 out of 228 
4 out of 546 
2 out of 21 
Years Active: 1997-2014
Areas of Expertise:
Title: **Wolfram Eichner: Innovator in Bioconjugate Chemistry**
Introduction
Wolfram Eichner, a prolific inventor based in Butzbach, Germany, has made significant contributions to the field of bioconjugate chemistry. With a remarkable total of 17 patents to his name, he is known for his innovative approaches to the coupling of proteins and polysaccharides, paving the way for advancements in pharmaceutical applications.
Latest Patents
Eichner's latest inventions include two notable patents focused on the coupling of proteins to modified polysaccharides. The first invention describes a method for coupling proteins to a starch-derived modified polysaccharide, which relies on a covalent bond formed between the polysaccharide's terminal aldehyde group and the protein's functional group. This binding interaction creates robust conjugates that can be further modified to enhance their efficacy. The invention also encompasses pharmaceutical compositions featuring these conjugates for therapeutic use in humans and animals.
His second patent provides insights into the formation of conjugates of hydroxyalkyl starch and proteins, emphasizing the covalent linkage between the starch or its derivatives and the proteins. This innovation outlines the production methods of such conjugates and their potential applications in various industries.
Career Highlights
Throughout his career, Wolfram Eichner has collaborated with notable organizations, including Fresenius Kabi Deutschland GmbH and Beiersdorf AG. His work in these companies allowed him to refine his skills in bioconjugate chemistry and contribute to the development of cutting-edge pharmaceutical solutions.
Collaborations
Wolfram has worked alongside esteemed colleagues such as Klaus Sommermeyer and Michele Orlando. These collaborations have fostered a dynamic exchange of ideas and innovation, further enhancing the impact of their collective work in the industry.
Conclusion
Wolfram Eichner stands out as a visionary inventor whose work is instrumental in advancing the field of bioconjugate chemistry. His innovative patents demonstrate a commitment to enhancing therapeutic methodologies through the strategic coupling of proteins and polysaccharides. As he continues to push the boundaries of scientific research, his contributions will undoubtedly leave a lasting mark on the pharmaceutical landscape.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile